Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations

Table 1 Dempgraphic parameters of patients undergoing percutaneous and surgical radiofrequency ablation

Parameters	Patients undergoing percutaneous RFA (n = 63)	Patients undergoing surgical RFA (n = 93)	P value
Age (yr)	57.8 ± 16.1	52.4 ± 11.7	0.531
Gender (M/F)	55/14	81/12	0.205
HBV infected	58	91	0.006
HCV infected	1	0
None-HBV&HCV	10	2
Liver cirrhosis	46	71	0.174
AST (IU/L)	47.3 ± 36.2	44.6 ± 33.8	0.311
ALT (IU/L)	42.3 ± 31.4	44.1 ± 19.6	0.354
TB (μmol/L)	15.4 ± 3.4	14.2 ± 5.6	0.601
ALB (g/L)	39.1 ± 9.8	41.7 ± 5.4	0.852
Child A/B	61/8	93/0	0.001
PLT (< 1011)	13	9	0.092
PT (> 15’)	6	14	0.224
Tumor number, 1/2/3	51/16/2	79/13/1	0.095
Tumor size (cm), > 3/ ≤ 3	11/78	23/85	0.099
Solitary HCC (cm), ≤ 3	39	62	0.188
Tumor in dangerous locations	73	95	0.242
AFP (ng/mL), ≤ 400/> 400/> 1210	13/41/15	17/60/16	0.000

Non-hepatitis B virus (HBV) & hepatitis C virus (HCV): Patients who were negative for HBV and HCV antibody but not for anti-HBs. RFA: Radiofrequency ablation; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; AFP: α fetoprotein; TB: Total bilirubin; PLT: Platelet; PT: Prothrombin time; ALB: Albumin.